Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ABVX – Abivax ADR

ABVX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.74

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

0.45

EPS Last/This Y

2

EPS This/Next Y

0.79

Price

121.96

Target Price

146.67

Analyst Recom

1.41

Performance Q

-8.22

Upside

-255.2%

Beta

0.83

Ticker: ABVX




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23ABVX112.920.511.2874194
2026-04-24ABVX114.540.550.2376850
2026-04-27ABVX112.060.580.4567568
2026-04-28ABVX109.890.590.2270584
2026-04-29ABVX106.240.570.5473358
2026-04-30ABVX117.370.570.3075526
2026-05-01ABVX117.460.540.1879926
2026-05-04ABVX117.210.560.6273595
2026-05-05ABVX123.780.560.2375098
2026-05-06ABVX126.780.530.6081094
2026-05-07ABVX124.640.530.2284894
2026-05-08ABVX122.680.520.4386448
2026-05-11ABVX122.210.520.6980494
2026-05-12ABVX121.870.561.4384270
2026-05-13ABVX121.820.580.1386513
2026-05-14ABVX120.960.540.5091105
2026-05-15ABVX114.520.551.0392483
2026-05-18ABVX113.610.520.5269202
2026-05-19ABVX113.640.540.6373079
2026-05-20ABVX119.840.560.5877519
2026-05-21ABVX124.040.550.4781024
2026-05-22ABVX121.990.550.9788181
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23ABVX112.93- - -3.63
2026-04-24ABVX114.52- - -3.63
2026-04-27ABVX111.94- - -3.63
2026-04-28ABVX109.82- - -3.64
2026-04-29ABVX106.35- - -3.64
2026-04-30ABVX117.34- - -3.64
2026-05-01ABVX117.47- - -3.64
2026-05-04ABVX117.12- - -3.64
2026-05-05ABVX123.71- - -3.64
2026-05-06ABVX126.56- - -3.64
2026-05-07ABVX124.66- - -3.64
2026-05-08ABVX122.65- - -3.64
2026-05-11ABVX122.21- - -3.64
2026-05-12ABVX121.47- - -3.64
2026-05-13ABVX121.87- - -3.64
2026-05-14ABVX120.98- - -3.64
2026-05-15ABVX114.58- - -3.64
2026-05-18ABVX113.60- - -3.64
2026-05-19ABVX113.71- - -3.64
2026-05-20ABVX119.84- - -3.65
2026-05-21ABVX124.14- - -3.65
2026-05-22ABVX121.96- - -3.65
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23ABVX0.00-8.024.90
2026-04-24ABVX0.00-8.024.90
2026-04-27ABVX0.00-6.363.84
2026-04-28ABVX0.00-6.363.84
2026-04-29ABVX0.00-6.363.84
2026-04-30ABVX0.00-6.363.84
2026-05-01ABVX0.00-6.363.84
2026-05-04ABVX0.00-5.763.84
2026-05-05ABVX0.00-5.763.84
2026-05-06ABVX0.00-5.763.84
2026-05-07ABVX0.00-5.763.84
2026-05-08ABVX0.00-5.763.84
2026-05-11ABVX0.00-4.983.82
2026-05-12ABVX0.00-4.983.80
2026-05-13ABVX0.00-4.983.80
2026-05-14ABVX0.00-4.983.80
2026-05-15ABVX0.00-4.983.80
2026-05-18ABVX0.00-4.933.79
2026-05-19ABVX0.00-4.933.79
2026-05-20ABVX0.00-4.933.79
2026-05-21ABVX0.00-4.933.74
2026-05-22ABVX0.00-4.933.74
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-1.19

Avg. EPS Est. Current Quarter

-0.81

Avg. EPS Est. Next Quarter

-0.74

Insider Transactions

Institutional Transactions

-4.93

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

14

Growth Score

23

Sentiment Score

98

Actual DrawDown %

18

Max Drawdown 5-Year %

Target Price

146.67

P/E

Forward P/E

PEG

P/S

P/B

17.92

P/Free Cash Flow

EPS

-5.41

Average EPS Est. Cur. Y​

-3.65

EPS Next Y. (Est.)

-2.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.18

Return on Equity vs Sector %

-100.9

Return on Equity vs Industry %

-85.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

ABVX Healthcare
$121.99
📉
Swing / Pullback
Buy the dip on strong trends
45 /100
WEAK
Trend
18/20
Pullback
11/25
Volume
4/15
Valuation
7/20
TP/AR
2/10
Options
3/10
RSI
54.3
Range 1M
63.7%
Sup Dist
2.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
33 /100
WEAK
Momentum
10/25
Growth
17/30
Estimates
0/20
Inst/Vol
3/15
Options
3/10
EPS Yr
27.7%
EPS NY
18.8%
52W%
80.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +20.2% upside
Quality
2/30
Valuation
6/30
Growth
12/25
Stability
5/10
LT Trend
4/5
Upside
+20.2%
Quality
14
Abivax SA
Sector: Healthcare
Industry: Biotechnology
Employees: 69
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
ABVX

Latest News

Caricamento notizie per ABVX
stock quote shares ABVX – Abivax ADR Stock Price stock today
news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch ABVX – Abivax ADR yahoo finance google finance
stock history ABVX – Abivax ADR invest stock market
stock prices ABVX premarket after hours
ticker ABVX fair value insiders trading

SNY – Sanofi

SNY — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.33

Margin Of Safety %

29

Put/Call OI Ratio

1.02

EPS Next Q Diff

0.55

EPS Last/This Y

1.07

EPS This/Next Y

0.37

Price

44.28

Target Price

53.92

Analyst Recom

2.29

Performance Q

-6.2

Upside

-29.8%

Beta

0.33

Ticker: SNY




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23SNY47.561.110.1153063
2026-04-24SNY46.811.190.3351942
2026-04-27SNY45.911.200.9852161
2026-04-28SNY45.971.200.5452805
2026-04-29SNY46.041.201.1052895
2026-04-30SNY46.571.210.8254701
2026-05-01SNY46.11.210.0655824
2026-05-04SNY43.311.311.0355308
2026-05-05SNY43.391.240.1455494
2026-05-06SNY43.741.180.2656449
2026-05-07SNY43.191.150.1156833
2026-05-08SNY43.311.100.1857242
2026-05-11SNY42.51.080.5158160
2026-05-12SNY42.851.070.8458391
2026-05-13SNY42.441.060.8659576
2026-05-14SNY42.851.060.4760839
2026-05-15SNY42.691.040.3161626
2026-05-18SNY43.541.080.2058524
2026-05-19SNY43.561.080.3158801
2026-05-20SNY44.681.070.2659602
2026-05-21SNY44.931.030.2261408
2026-05-22SNY44.281.020.8261726
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23SNY47.530.54462.14.83
2026-04-24SNY46.780.53970.14.83
2026-04-27SNY45.8924.34476.64.83
2026-04-28SNY45.9624.34648.64.96
2026-04-30SNY46.5824.34892.04.96
2026-05-01SNY46.1024.34576.74.80
2026-05-04SNY43.3124.34294.84.80
2026-05-05SNY43.3724.34778.24.81
2026-05-06SNY43.7424.34865.34.81
2026-05-07SNY43.1924.34348.94.81
2026-05-08SNY43.2924.34498.94.81
2026-05-11SNY42.4924.34438.24.81
2026-05-12SNY42.8524.34507.74.81
2026-05-13SNY42.4424.34412.54.81
2026-05-14SNY42.8624.34606.54.81
2026-05-15SNY42.7024.34496.04.81
2026-05-18SNY43.5624.34601.44.81
2026-05-19SNY43.5524.34393.14.81
2026-05-20SNY44.6824.34525.54.81
2026-05-21SNY44.9124.34402.64.81
2026-05-22SNY44.2824.34162.24.81
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23SNY0.00-4.920.31
2026-04-24SNY0-4.920.31
2026-04-27SNY0-5.800.32
2026-04-28SNY0-5.800.32
2026-04-29SNY0-5.800.32
2026-04-30SNY0-5.800.32
2026-05-01SNY0-5.800.32
2026-05-04SNY0-3.120.32
2026-05-05SNY0-3.120.32
2026-05-06SNY0-3.120.32
2026-05-07SNY0-3.120.32
2026-05-08SNY0-3.120.32
2026-05-11SNY0-3.670.32
2026-05-12SNY0-3.670.33
2026-05-13SNY0-3.670
2026-05-14SNY0-3.670.33
2026-05-15SNY0-3.670.33
2026-05-18SNY0-2.600.33
2026-05-19SNY0-2.600.33
2026-05-20SNY0-2.600.33
2026-05-21SNY0-2.600.33
2026-05-22SNY0-2.600.33
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.1

Avg. EPS Est. Current Quarter

1.13

Avg. EPS Est. Next Quarter

1.65

Insider Transactions

Institutional Transactions

-2.6

Beta

0.33

Average Sales Estimate Current Quarter

10812

Average Sales Estimate Next Quarter

13273

Fair Value

57.07

Quality Score

91

Growth Score

78

Sentiment Score

96

Actual DrawDown %

26.3

Max Drawdown 5-Year %

-33.5

Target Price

53.92

P/E

18.55

Forward P/E

8.33

PEG

1.15

P/S

2.15

P/B

1.28

P/Free Cash Flow

10.14

EPS

2.39

Average EPS Est. Cur. Y​

4.81

EPS Next Y. (Est.)

5.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.81

Relative Volume

0.81

Return on Equity vs Sector %

-21.8

Return on Equity vs Industry %

-31.9

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.2

EBIT Estimation

4162.2
SNY Healthcare
$44.29
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
18/20
Pullback
11/25
Volume
7/15
Valuation
18/20
TP/AR
1/10
Options
3/10
RSI
47.8
Range 1M
32.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
21 /100
WEAK
Momentum
6/25
Growth
9/30
Estimates
5/20
Inst/Vol
0/15
Options
1/10
EPS Yr
6.9%
EPS NY
6.5%
52W%
19.1%
💎
Long-Term Value
Quality companies, undervalued
46 /100
WEAK
🟢 BUY +39.2% upside
Quality
14/30
Valuation
18/30
Growth
7/25
Stability
3/10
LT Trend
4/5
Upside
+39.2%
Quality
91
MoS
29%
Sanofi
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 74846
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
SNY

Latest News

Caricamento notizie per SNY
stock quote shares SNY – Sanofi Stock Price stock today
news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025
marketwatch SNY – Sanofi yahoo finance google finance
stock history SNY – Sanofi invest stock market
stock prices SNY premarket after hours
ticker SNY fair value insiders trading

TTE – Total Energies SE

TTE — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.21

Margin Of Safety %

5

Put/Call OI Ratio

0.78

EPS Next Q Diff

0.41

EPS Last/This Y

5.61

EPS This/Next Y

-1.39

Price

91.6

Target Price

97.38

Analyst Recom

2.22

Performance Q

17.78

Upside

-2.1%

Beta

0.16

Ticker: TTE




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23TTE90.460.790.4281401
2026-04-24TTE89.730.803.7681809
2026-04-27TTE88.720.800.1582082
2026-04-28TTE91.010.810.0282073
2026-04-29TTE92.30.780.0683795
2026-04-30TTE92.70.770.9584601
2026-05-01TTE92.80.770.0584940
2026-05-04TTE92.320.794.1484060
2026-05-05TTE93.560.800.0385114
2026-05-06TTE89.910.800.6985336
2026-05-07TTE88.690.800.5085316
2026-05-08TTE88.480.790.9385065
2026-05-11TTE90.660.800.2385835
2026-05-12TTE91.720.801.0885962
2026-05-13TTE91.420.800.6185962
2026-05-14TTE91.380.791.7186042
2026-05-15TTE92.240.790.0986042
2026-05-18TTE93.460.840.1372142
2026-05-19TTE92.90.780.1975507
2026-05-20TTE92.510.780.3775719
2026-05-21TTE92.350.781.0075736
2026-05-22TTE91.660.780.1875836
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23TTE90.49- 917.810.93
2026-04-24TTE89.73- 8370.110.88
2026-04-27TTE88.74- 8190.511.11
2026-04-28TTE91.06- 9509.511.11
2026-04-30TTE92.71- 9849.511.11
2026-05-01TTE92.72- 7234.211.11
2026-05-04TTE92.28- 7444.711.13
2026-05-05TTE93.59- 8113.612.34
2026-05-06TTE89.93- 6484.212.34
2026-05-07TTE88.71- 8047.312.47
2026-05-08TTE88.47- 8661.211.68
2026-05-11TTE90.69- 8110.311.68
2026-05-12TTE91.74- 8022.111.78
2026-05-13TTE91.40- 7350.311.78
2026-05-14TTE91.39- 7826.711.77
2026-05-15TTE92.24- 7928.311.77
2026-05-18TTE93.43- 8176.311.77
2026-05-19TTE92.89- 7611.911.77
2026-05-20TTE92.53- 7189.111.45
2026-05-21TTE92.37- 7348.711.45
2026-05-22TTE91.60- 6879.411.45
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23TTE0.00-15.140.21
2026-04-24TTE0.00-15.140.21
2026-04-27TTE0.00-13.860.20
2026-04-28TTE0.00-13.860.20
2026-04-29TTE0.00-13.860.20
2026-04-30TTE0.00-13.860.20
2026-05-01TTE0.00-13.860.20
2026-05-04TTE0.00-7.930.19
2026-05-05TTE0.00-7.930.19
2026-05-06TTE0.00-7.930.19
2026-05-07TTE0.00-7.930.19
2026-05-08TTE0.00-7.930.19
2026-05-11TTE0.00-9.120.19
2026-05-12TTE0.00-9.120.21
2026-05-13TTE0.00-9.120.21
2026-05-14TTE0.00-9.120.21
2026-05-15TTE0.00-9.120.21
2026-05-18TTE0.00-13.020.21
2026-05-19TTE0.00-13.020.21
2026-05-20TTE0.00-13.020.21
2026-05-21TTE0.00-13.020.21
2026-05-22TTE0.00-13.020.21
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

2.45

Avg. EPS Est. Current Quarter

2.84

Avg. EPS Est. Next Quarter

2.86

Insider Transactions

Institutional Transactions

-13.02

Beta

0.16

Average Sales Estimate Current Quarter

52436

Average Sales Estimate Next Quarter

50267

Fair Value

95.86

Quality Score

80

Growth Score

47

Sentiment Score

100

Actual DrawDown %

2.7

Max Drawdown 5-Year %

-26.3

Target Price

97.38

P/E

13.28

Forward P/E

9.57

PEG

0.87

P/S

1.11

P/B

1.6

P/Free Cash Flow

18.32

EPS

6.9

Average EPS Est. Cur. Y​

11.45

EPS Next Y. (Est.)

10.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.2

Relative Volume

0.48

Return on Equity vs Sector %

2.1

Return on Equity vs Industry %

2.6

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

0.29

EBIT Estimation

6879.4
TTE Energy
$91.67
📉
Swing / Pullback
Buy the dip on strong trends
36 /100
WEAK
Trend
0/20
Pullback
7/25
Volume
11/15
Valuation
10/20
TP/AR
5/10
Options
3/10
RSI
52.8
Range 1M
63%
🚀
Momentum Growth
Ride accelerating trends
N/A
43 /100
WEAK
Momentum
4/25
Growth
19/30
Estimates
10/20
Inst/Vol
3/15
Options
7/10
EPS Yr
55.5%
EPS NY
-10.6%
52W%
93.6%
💎
Long-Term Value
Quality companies, undervalued
40 /100
WEAK
🟡 HOLD +24% upside
Quality
8/30
Valuation
13/30
Growth
15/25
Stability
3/10
LT Trend
1/5
Upside
+24%
Quality
80
MoS
5%
TotalEnergies SE
Sector: Energy
Industry: Oil & Gas Integrated
Employees: 94847
TotalEnergies SE, an integrated energy company, produces and markets oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables, and electricity in France, the United States, Europe, Brazil, India, and internationally. The company was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. TotalEnergies SE was incorporated in 1924 and is headquartered in Courbevoie, France.
TTE

Latest News

Caricamento notizie per TTE
stock quote shares TTE – Total Energies SE Stock Price stock today
news today TTE – Total Energies SE stock forecast ,stock prediction 2023 2024 2025
marketwatch TTE – Total Energies SE yahoo finance google finance
stock history TTE – Total Energies SE invest stock market
stock prices TTE premarket after hours
ticker TTE fair value insiders trading

CSTM – Constellium SE

CSTM — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

5.54

Margin Of Safety %

-4

Put/Call OI Ratio

0.45

EPS Next Q Diff

-0.48

EPS Last/This Y

1.07

EPS This/Next Y

-0.49

Price

33.24

Target Price

37.6

Analyst Recom

1.4

Performance Q

30.97

Upside

21.2%

Beta

1.54

Ticker: CSTM




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23CSTM30.260.5912.8231683
2026-04-24CSTM31.390.720.5034325
2026-04-27CSTM31.20.712.2734550
2026-04-28CSTM31.080.820.1537660
2026-04-29CSTM32.220.812.8038140
2026-04-30CSTM31.290.870.4039709
2026-05-01CSTM32.020.870.5339969
2026-05-04CSTM30.840.870.9140399
2026-05-05CSTM32.980.870.3640635
2026-05-06CSTM33.310.870.2040605
2026-05-07CSTM32.910.870.6640719
2026-05-08CSTM33.890.872.0440825
2026-05-11CSTM34.20.881.0041187
2026-05-12CSTM33.30.870.6041464
2026-05-13CSTM34.550.860.1641647
2026-05-14CSTM33.50.870.5141575
2026-05-15CSTM31.910.870.1241801
2026-05-18CSTM32.260.440.3026505
2026-05-19CSTM31.240.430.2827292
2026-05-20CSTM32.120.450.3627241
2026-05-21CSTM32.040.440.5227378
2026-05-22CSTM33.240.450.2927664
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23CSTM30.2799.1- 1.78
2026-04-24CSTM31.3999.1- 1.78
2026-04-27CSTM31.2099.1- 1.78
2026-04-28CSTM31.0999.1- 1.78
2026-04-30CSTM31.2899.1- 1.78
2026-05-01CSTM32.0099.1- 1.78
2026-05-04CSTM30.83843.4- 2.95
2026-05-05CSTM32.97843.4- 2.87
2026-05-06CSTM33.33843.4- 2.87
2026-05-07CSTM32.85843.4- 2.87
2026-05-08CSTM33.89843.4- 3.02
2026-05-11CSTM34.19843.4- 3.02
2026-05-12CSTM33.31843.4- 3.02
2026-05-13CSTM34.56843.4- 3.02
2026-05-14CSTM33.50843.4- 3.02
2026-05-15CSTM31.92843.4- 3.02
2026-05-18CSTM32.26843.4- 3.02
2026-05-19CSTM31.23843.4- 3.02
2026-05-20CSTM32.13843.4- 3.02
2026-05-21CSTM32.04843.4- 3.02
2026-05-22CSTM33.24843.4- 3.02
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23CSTM-1.45-2.636.12
2026-04-24CSTM-1.45-2.636.17
2026-04-27CSTM-1.34-2.176.21
2026-04-28CSTM-1.34-2.176.21
2026-04-29CSTM-1.34-2.176.21
2026-04-30CSTM-1.35-2.176.22
2026-05-01CSTM-1.34-2.176.22
2026-05-04CSTM-1.66-4.236.22
2026-05-05CSTM-1.95-4.236.22
2026-05-06CSTM-1.95-4.236.22
2026-05-07CSTM-2.16-4.236.22
2026-05-08CSTM-2.17-4.236.22
2026-05-11CSTM-2.17-3.886.22
2026-05-12CSTM-2.34-3.885.55
2026-05-13CSTM-2.34-3.885.55
2026-05-14CSTM-2.34-3.885.55
2026-05-15CSTM-2.34-3.885.54
2026-05-18CSTM-2.37-2.965.54
2026-05-19CSTM-2.38-2.965.54
2026-05-20CSTM-2.38-2.965.54
2026-05-21CSTM-2.38-2.965.54
2026-05-22CSTM-2.38-2.965.54
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.02

Avg. EPS Est. Current Quarter

0.81

Avg. EPS Est. Next Quarter

0.54

Insider Transactions

-2.38

Institutional Transactions

-2.96

Beta

1.54

Average Sales Estimate Current Quarter

2308

Average Sales Estimate Next Quarter

2251

Fair Value

31.87

Quality Score

74

Growth Score

88

Sentiment Score

38

Actual DrawDown %

4.9

Max Drawdown 5-Year %

-66.3

Target Price

37.6

P/E

10.73

Forward P/E

12.15

PEG

0.38

P/S

0.51

P/B

4.04

P/Free Cash Flow

25.72

EPS

3.1

Average EPS Est. Cur. Y​

3.02

EPS Next Y. (Est.)

2.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.87

Relative Volume

0.87

Return on Equity vs Sector %

22.6

Return on Equity vs Industry %

24.5

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.29

EBIT Estimation

CSTM Basic Materials
$33.24
📉
Swing / Pullback
Buy the dip on strong trends
55 /100
WATCH
Trend
20/20
Pullback
6/25
Volume
7/15
Valuation
9/20
TP/AR
6/10
Options
7/10
RSI
57.7
Range 1M
66.9%
Sup Dist
5.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
58 /100
WATCH
Momentum
13/25
Growth
23/30
Estimates
9/20
Inst/Vol
4/15
Options
9/10
EPS Yr
169%
EPS NY
-17.8%
52W%
92.9%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +0.8% upside
Quality
13/30
Valuation
8/30
Growth
18/25
Stability
2/10
LT Trend
4/5
Upside
+0.8%
Quality
74
MoS
-4%
Constellium SE
Sector: Basic Materials
Industry: Aluminum
Employees: 11500
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets. It operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces and develops rolled aluminum products, including canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. This segment also supplies automotive body sheets, heat exchangers, and battery foil products for the automotive market. The Aerospace & Transportation segment provides aluminum products including plate, sheet, and extrusions to aerospace, space, commercial transportation, general industrial, and defense sectors. The Automotive Structures & Industry segment offers structural solutions for the automotive industry including crash management systems, body structures, side impact beams, and battery enclosure components; soft and hard alloy extrusions for automotive, transportation, and general industrial applications; and profiles for rail and general industrial applications. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. It sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as South Korea, Japan and China. The company was incorporated in 2010 and is headquartered in Paris, France.
CSTM

Latest News

Caricamento notizie per CSTM
stock quote shares CSTM – Constellium SE Stock Price stock today
news today CSTM – Constellium SE stock forecast ,stock prediction 2023 2024 2025
marketwatch CSTM – Constellium SE yahoo finance google finance
stock history CSTM – Constellium SE invest stock market
stock prices CSTM premarket after hours
ticker CSTM fair value insiders trading